Home Zacks Investment Research Upgrades Immunomedics, Inc. (IMMU) to Buy
 

Keywords :   


Zacks Investment Research Upgrades Immunomedics, Inc. (IMMU) to Buy

2016-04-11 03:27:16| Biotech - Topix.net

The firm currently has a $3.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price target points to a potential upside of 12.78% from the company's previous close.

Tags: buy research investment upgrades

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »